Abstract

Immunization of the population through vaccination against COVID-19 is recognized as a public health priority. The most difficult scientific challenge for vaccines is the clinical safety and efficacy. We report a patient presenting with Fusobacterium nucleatum bacteremia and liver abscess formation following administration of anti-COVID-19 viral-vectored vaccine.